Touchlight announced today that its proprietary z- dbDNA™ technology is to be utilised as a critical starting material in the manufacture of a cutting-edge gene therapy for a US-based clinical…
Read More
Touchlight, a pioneering leader in DNA manufacturing technologies, has been named the 2025 FOYA Category Winner for Innovation in the International Society for Pharmaceutical Engineering (ISPE) Facility of the Year…
Read More
Touchlight Introduces mbDNA™: A “best-in-class" circular single stranded DNA (ssDNA) platform enabling superior gene editing Published: 30 July 2025Touchlight, a pioneer in cell-free DNA innovation, is proud to announce the…
Read More
Touchlight Wins ISPE Facility of the Year Award for Innovation, Recognised for Revolutionary dbDNA™ Manufacturing at Morelands Facility Published: 12 May 2025Touchlight, a pioneering leader in synthetic DNA technology, is…
Read More
Touchlight Appoints Industry Leader Will Downie as Adviser to Support Strategic Growth in Synthetic DNA Platforms Published: 27 January 2025 Touchlight Genetics, in partnership with the National Physical Laboratory (NPL)…
Read More
20Med Therapeutics and Touchlight to collaborate on novel vaccine delivery platform project Published: 18 April 2023 Curia collaborates with Touchlight to expand its mRNA manufacturing offering to enable access to…
Read More
Touchlight announces first FDA clearance of an IND utilising doggybone DNA Published: 28 February 2023 Enzymatic doggybone DNA material used in GMP production of a cell therapy by a US-based…
Read More
